Primary Pure Squamous Cell Carcinoma of the Breast Might Be Sensitive to Cisplatin-Based Chemotherapy

Publisher： Karger

E-ISSN： 1662-6575|5|3|561-565

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.5, Iss.3, 2012-10, pp. : 561-565

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long‐term results of weekly/daily cisplatin‐based chemoradiation for locally advanced squamous cell carcinoma of the anal canal

By  

CANCER, Vol. 119, Iss. 21, 2013-11 ,pp. : 3769-3775

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cisplatin Combination Chemotherapy in Squamous Cell Carcinoma and Adenoid Cystic Carcinoma of the Skin

By  

THE JOURNAL OF DERMATOLOGY, Vol. 16, Iss. 3, 1989-06 ,pp. : 227-230

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive Role of ERCC1 Expression in Head and Neck Squamous Cell Carcinoma Patients Treated with Surgery and Adjuvant Cisplatin-Based Chemoradiation

By  

Oncology, Vol. 89, Iss. 4, 2015-06 ,pp. : 227-234

Karger

Access to resources Recommend Favorite

Randomized phase III study of 2 cisplatin‐based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: Impact of changing disease epidemiology on contemporary trial design

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 11, 2015-11 ,pp. : 1583-1589

John Wiley & Sons Inc

Access to resources Recommend Favorite

RASSF1A and ERCC1 Expression Levels Might Be Predictive of Prognosis in Advanced, Recurrent, and Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with Docetaxel and Cisplatin

By  

Oncology Research and Treatment, Vol. 35, Iss. 11, 2012-10 ,pp. : 673-682

Karger

Access to resources Recommend Favorite